Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Abbott

Abbott

Sep 21, 2020

FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

One of the revisions specifies that the ID Now test is for use with specimens collected within the first week of symptom onset.

Sep 08, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza

Premium

Healthcare providers need multiplexed tests that can differentiate the flu from the coronavirus so they can treat patients quickly and appropriately.

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

While the market ditched shares of many other diagnostics firms, analysts said the reaction was overblown, particularly in the case of Quidel and molecular diagnostics players.

Aug 27, 2020

Cheap and Fast

The US Food and Drug Administration has issued an Emergency Use Authorization for Abbott's antigen test for SARS-CoV-2.

Jul 21, 2020

AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry

According to the registry's first dataset, more than 65 million tests have been manufactured and shipped across the US.

Jul 17, 2020

Weathering COVID-19 Pandemic, Abbott Beats Analyst Q2 Expectations on Coronavirus Testing Demand

Premium

Significant revenue from molecular and rapid diagnostic testing for SARS-CoV-2 offset declines in core lab volumes.

Jul 16, 2020

Abbott Q2 Diagnostics Revenues Rise 5 Percent, MDx Revenues Skyrocket

The firm's various COVID-19 molecular test offerings offset declines in core laboratory and point-of-care segments.

Jun 12, 2020

In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More

News items for the week of June 8, 2020.

Jun 01, 2020

Sema4 Forms Coronavirus Testing Alliance With Connecticut

Sema4 said it will provide SARS-CoV-2 viral and antibody testing to Connecticut residents including state employees and first responders.

May 28, 2020

And Now Machines

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

Pages

The Scan

And Maybe Not

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Now Onto a Hungry Caterpillar

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

This Variant Here

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

Nature Papers Present Tool for Topological Analysis of Chromosomes, Map of Genome-Lipid Associations

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.

What's Popular?

In Abbott

  1. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.